Treatment of gout.
M G
MG
Cohen
D000368:Aged; D000493:Allopurinol / Q000008:administration & dosage / Q000627:therapeutic use*; D001315:Australia; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D000069465:Febuxostat; D005919:Glomerular Filtration Rate; D006073:Gout / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006074:Gout Suppressants / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000628:therapy; D008297:Male; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000627:therapeutic use; D006435:Renal Dialysis; D013844:Thiazoles / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood
D006074:Gout Suppressants; D013844:Thiazoles; D000069465:Febuxostat; D014527:Uric Acid; D000493:Allopurinol; D011239:Prednisolone; D003078:Colchicine